搜索临床试验以:Sodium-glucose co-transporter 2 (SGLT2) inhibitor
总计103936个结果
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital招聘中
-
University of BirminghamUniversity College, London; National Institute for Health Research, United Kingdom招聘中
-
National Heart Centre SingaporeNational Taiwan University Hospital; Mackay Memorial Hospital; Peking University People's Hospital 和其他合作者招聘中
-
Lawson Health Research InstituteJanssen Inc.完全的
-
YangjinPeking University Third Hospital尚未招聘
-
Eli Lilly and Company完全的
-
Janssen Research & Development, LLC完全的
-
Medical University of WarsawMedical University of Graz; Medical University of Vienna; Poznan University of Medical Sciences; Medical University of Gdansk 和其他合作者招聘中
-
University Hospitals Cleveland Medical Center终止
-
The University of Texas Health Science Center at...National Institute on Aging (NIA)完全的
-
Steno Diabetes Center CopenhagenUniversity of Copenhagen完全的
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute招聘中
-
Changzhou No.2 People's Hospital未知
-
General and Teaching Hospital Celje完全的糖尿病,1 型 | 生物标志物 | 内皮功能障碍 | 动脉硬化 | 口蹄疫 | 肠促胰岛素 | 内皮祖细胞 | SGLT 2 抑制剂 | 葡萄糖偏移 | FPF斯洛文尼亚
-
AstraZenecaContract Research Organization: USA; PAREXEL Early Phase Clinical Unit Baltimore; PAREXEL Early... 和其他合作者完全的
-
Icahn School of Medicine at Mount Sinai招聘中
-
Pathalys PharmaLaunch Therapeutics招聘中
-
Novo Nordisk A/S完全的
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São Paulo完全的高血压 | 肥胖 | 2型糖尿病 | 血压 | 血管僵硬 | 心脏肥大 | 微量白蛋白尿巴西